107 related articles for article (PubMed ID: 30078474)
21. Synthesis and biological activity of nociceptin/orphanin FQ(1-13)NH2 analogues modified in 9 and/or 13 position.
Naydenova ED; Zhivkova VI; Zamfirova RN; Vezenkov LT; Dobrinova YG; Mateeva PI
Bioorg Med Chem Lett; 2006 Aug; 16(15):4071-4. PubMed ID: 16714110
[TBL] [Abstract][Full Text] [Related]
22. Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.
Perlikowska R; Piekielna J; Mazur M; Koralewski R; Olczak J; do Rego JC; Fichna J; Modranka J; Janecki T; Janecka A
Bioorg Med Chem; 2014 Sep; 22(17):4803-9. PubMed ID: 25047937
[TBL] [Abstract][Full Text] [Related]
23. Bioactive peptidic analogues and cyclostereoisomers of the minimal antinociceptive histogranin fragment-(7-10).
Le HT; Lemaire IB; Gilbert AK; Jolicoeur F; Lemaire S
J Med Chem; 2003 Jul; 46(14):3094-101. PubMed ID: 12825947
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and structural studies of new analogues of PTH(1-11) containing Cα-tetra-substituted amino acids in position 8.
Caporale A; Sturlese M; Schievano E; Mammi S; Peggion E
Amino Acids; 2010 Nov; 39(5):1369-79. PubMed ID: 20431900
[TBL] [Abstract][Full Text] [Related]
25. Crotalphine, a novel potent analgesic peptide from the venom of the South American rattlesnake Crotalus durissus terrificus.
Konno K; Picolo G; Gutierrez VP; Brigatte P; Zambelli VO; Camargo AC; Cury Y
Peptides; 2008 Aug; 29(8):1293-304. PubMed ID: 18495297
[TBL] [Abstract][Full Text] [Related]
26. Convolutamydine A and synthetic analogues have antinociceptive properties in mice.
Figueiredo GS; Zardo RS; Silva BV; Violante FA; Pinto AC; Fernandes PD
Pharmacol Biochem Behav; 2013 Jan; 103(3):431-9. PubMed ID: 23046852
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7.
Fruitier I; Garreau I; Piot JM
Biochem Biophys Res Commun; 1998 May; 246(3):719-24. PubMed ID: 9618278
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
29. Kinetic of in vitro generation of some hemorphins: early release of LVV-hemorphin-7, precursor of VV-hemorphin-7.
Dagouassat N; Garreau I; Zhao Q; Sannier F; Piot JM
Neuropeptides; 1996 Feb; 30(1):1-5. PubMed ID: 8868292
[TBL] [Abstract][Full Text] [Related]
30. Structure-function relationship studies of PTH(1-11) analogues containing D-amino acids.
Caporale A; Biondi B; Schievano E; Wittelsberger A; Mammi S; Peggion E
Eur J Pharmacol; 2009 Jun; 611(1-3):1-7. PubMed ID: 19303868
[TBL] [Abstract][Full Text] [Related]
31. Peptide fragments derived from the beta-chain of hemoglobin (hemorphins) are centrally active in vivo.
Davis TP; Gillespie TJ; Porreca F
Peptides; 1989; 10(4):747-51. PubMed ID: 2587417
[TBL] [Abstract][Full Text] [Related]
32. Opioid peptides derived from hemoglobin: hemorphins.
Zhao Q; Garreau I; Sannier F; Piot JM
Biopolymers; 1997; 43(2):75-98. PubMed ID: 9216245
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
Wieczorek Z; Słoń JJ; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and analgesic effects of novel β2-tryptophan hexapeptide analogs.
Bocheva A; Nocheva H; Pavlov N; Todorov P; Calmès M; Martinez J; Naydenova E
Amino Acids; 2013 Oct; 45(4):983-8. PubMed ID: 23851698
[TBL] [Abstract][Full Text] [Related]
35. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
36. [Effect of structural changes of Pro6 in dermorphin molecule on its antinociceptive activity].
Guzevatykh LS; Emel'ianova TG; Usenko AB; Andreeva LA; Alfeeva LIu; Voronina TA; Miasoedov NF
Izv Akad Nauk Ser Biol; 2002; (4):472-6. PubMed ID: 12180013
[TBL] [Abstract][Full Text] [Related]
37. Benzofuranones as potential antinociceptive agents: structure-activity relationships.
Gonçalves CJ; Lenoir AS; Padaratz P; Corrêa R; Niero R; Cechinel-Filho V; Campos Buzzi Fd
Eur J Med Chem; 2012 Oct; 56():120-6. PubMed ID: 22960698
[TBL] [Abstract][Full Text] [Related]
38. LVV- and VV-hemorphins: comparative levels in rat tissues.
Yatskin ON; Philippova MM; Blishchenko EYu ; Karelin AA; Ivanov VT
FEBS Lett; 1998 May; 428(3):286-90. PubMed ID: 9654150
[TBL] [Abstract][Full Text] [Related]
39. New N- and C-modified RGD-hemorphins as potential biomedical application on Ti-surface materials: synthesis, characterization and antinociceptive activity.
Georgieva S; Todorov P; Nikolov S; Dzhambazova E; Peneva P; Assenov B; Pechlivanova D
Mol Divers; 2023 Feb; 27(1):263-280. PubMed ID: 35438429
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice.
Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S
Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
